In Vivo Evaluation of <sup>68</sup>Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model
EGFRvIII is expressed only in tumor cells and strongly in glioblastoma and is considered a promising target in cancer diagnosis and therapy. Aptamers are synthetic single-stranded oligonucleotides that bind to biochemical target molecules with high binding affinity and specificity. This study examin...
Saved in:
Main Authors: | Jun Young Park (Author), Ye Lim Cho (Author), Tae Sup Lee (Author), Daekyun Lee (Author), Ju-Hyung Kang (Author), Soryong Lim (Author), Yujin Lee (Author), Jae Hyun Lim (Author), Won Jun Kang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
by: Zesheng Li, et al.
Published: (2023) -
Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
by: Xingmei Zhang, et al.
Published: (2023) -
Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
by: Xingmei Zhang, et al.
Published: (2018) -
[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020) -
Automated GMP Production and Preclinical Evaluation of [<sup>68</sup>Ga]Ga-TEoS-DAZA and [<sup>68</sup>Ga]Ga-TMoS-DAZA
by: Julia Greiser, et al.
Published: (2022)